Holen Sie sich die Stockscreener-App
283.72
10.56%
27.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$256.62
Offen:
$256.48
24-Stunden-Volumen:
4.47M
Relative Volume:
2.37
Marktkapitalisierung:
$34.12B
Einnahmen:
$123.11B
Nettoeinkommen (Verlust:
$1.58B
KGV:
21.78
EPS:
13.0294
Netto-Cashflow:
$2.44B
1W Leistung:
+11.28%
1M Leistung:
-9.06%
6M Leistung:
+6.87%
1J Leistung:
+17.35%
1-Tages-Spanne:
$255.01
$287.51
1-Wochen-Bereich:
$239.00
$287.51
52-Wochen-Spanne:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
283.72 | 30.86B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
360.20 | 320.35B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
77.49 | 98.23B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
311.00 | 79.27B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
350.50 | 76.61B | 189.25B | 5.35B | 5.34B | 23.49 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Important Notice to Long-Term Shareholders of Elevance Health, Inc. (NYSE: ELV); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire
Important Notice to Long-Term Shareholders of Elevance Health, Inc. (NYSE: ELV); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
AMF Tjanstepension AB Purchases Shares of 73,902 Humana Inc. $HUM - MarketBeat
Robeco Institutional Asset Management B.V. Buys 126,667 Shares of Humana Inc. $HUM - MarketBeat
Humana (NYSE:HUM) Shares Up 9.1%Here's What Happened - MarketBeat
Humana Inc. (HUM) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Analyzing Humana’s Stock Surge: What’s Next? - timothysykes.com
Humana rises over 15% in last two trading sessions - Seeking Alpha
Humana (HUM) Soars 11.9% Amidst Strong Market Confidence - FinancialContent
Why Humana’s Stock is Flying Upwards? - StocksToTrade
Humana Projects Strong 2025 Earnings Amidst Star Ratings Challenge - MSN
Humana’s Rapid Rise: Time to Jump In? - timothysykes.com
Wall Street Sets New Highs Despite Shutdown: Markets TodayHumana (NYSE:HUM) - Benzinga
Humana Faces Medicare Setbacks But Bets Big On Long-Term Care Growth (HUM) - Seeking Alpha
Humana: Long-Term Recovery Potential, Short-Term Pressure (NYSE:HUM) - Seeking Alpha
Guggenheim Reiterates "Buy" Rating on Humana (HUM) | HUM Stock N - GuruFocus
Guggenheim Reaffirms "Buy" Rating for Humana (NYSE:HUM) - MarketBeat
Stocks making big moves this week: Strategy, GoPro, Datadog, Dave, and Humana - The Globe and Mail
Signal strength of Humana Inc. stock in tech scanners2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Is Humana Inc. stock oversold or undervaluedJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Humana (HUM) Faces Mixed Reactions Following 2026 Star Ratings U - GuruFocus
Will Humana Inc. stock benefit from upcoming earnings reportsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
How Humana Inc. (HUM) stock benefits from digital adoption2025 Technical Overview & Smart Investment Allocation Tips - newser.com
What makes Humana Inc. stock attractive to growth funds2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Will Humana Inc. stock outperform Dow JonesJuly 2025 Snapshot & Community Verified Trade Alerts - newser.com
How to build a custom watchlist for Humana Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
How Humana Inc. stock reacts to weak economyTrade Volume Summary & Technical Pattern Based Signals - newser.com
Why Humana Inc. stock attracts global investors2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Humana Inc. stock chart pattern explainedJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
How Humana Inc. (HUM) stock correlates with oil markets2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com
Is Humana Inc. showing signs of accumulationJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Humana provides a peek into its Medicare Advantage plan ratings, and the stock jumps - MarketWatch
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana says fewer members in top-rated Medicare Advantage plans - Modern Healthcare
Humana (HUM) Reaffirms Earnings and 2026 Star Ratings Expectatio - GuruFocus
Humana Inc. (HUM) Reports on 2026 Medicare Advantage Star Ratings and Financial Guidance - GuruFocus
Humana sees 20% of its members in high-rated Medicare plans for 2026 - Reuters
Humana Affirms Outlook, Calls Medicare Ratings In-Line With View - Bloomberg.com
Humana gets in-line 2026 Medicare Star Ratings (HUM:NYSE) - Seeking Alpha
Humana sees 20% of its members in high-rated Medicare plans - CNBC
Humana (HUM) Projects Return to Top Quartile in 2027 MA Star Rat - GuruFocus
Humana Affirms Outlook, Calls Star Ratings In-Line With View - Mint
Humana (HUM) Expects Strong Growth and Profit Margins by 2026 - GuruFocus
Humana Stock Rises After Insurer Reaffirms Full-Year Earnings Guidance - Stocktwits
Humana stock rises after Medicare star ratings update - Investing.com
UnitedHealth to exit Medicare Advantage plans in 109 US counties - Reuters
UnitedHealthcare, Humana, Aetna scale back Medicare Advantage plans for 2026 - Healthcare Dive
Major health insurers scaling back Medicare Advantage offerings in 2026 - Fox Business
Humana ordered by federal court to pay $32 million in fees. Here's why - The Courier-Journal
Humana Benefits From Rising Premiums Amid High Benefit Ratio - Nasdaq
Humana's Medicaid Plans in Kentucky and Wisconsin Earn Four-Star Rating from NCQA - Humana
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):